Barreras y facilitadores del sistema de salud relacionadas con el seguimiento de anormalidades citológicas, Medellín-Colombia

ABSTRACT: Identifying barriers and facilitators of the diagnostic monitoring and treatment of cytological abnormalities in low-income women users of the public health service network in Medellin, Colombia. Methods: We created eight focal groups (62 women) according to age groups (ages 25-45 and 46-6...

Full description

Autores:
Garcés Palacio, Isabel Cristina
Rubio León, Diana Carolina
Ramos Jaraba, Sara Milena
Tipo de recurso:
Article of investigation
Fecha de publicación:
2014
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
spa
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/12083
Acceso en línea:
http://hdl.handle.net/10495/12083
Palabra clave:
Accesibilidad
Accessibility
Oportunidad
Opportunity
Seguimiento
Monitoring
Cáncer de cuello uterino
Cervical cancer
Barreras
Barriers
Anormalidades citológicas
Cytological abnormalities
Rights
openAccess
License
Atribución-NoComercial-SinDerivadas 2.5 Colombia
Description
Summary:ABSTRACT: Identifying barriers and facilitators of the diagnostic monitoring and treatment of cytological abnormalities in low-income women users of the public health service network in Medellin, Colombia. Methods: We created eight focal groups (62 women) according to age groups (ages 25-45 and 46-69), and performed a content analysis. Results: The reported barriers of the health system were: a) structural barriers: fragmentation in the provision of the service, problems with the affiliations and characteristics of the affiliation regime; b) management barriers: problems and delays in the assignment of appointments, long queues, problems with authorizations and mistreatment; and c) economic barriers derived from the aforementioned and related with expenses. Management and structural facilitators were also mentioned. Conclusion: Some structural characteristics of the health system and the management of insurance companies limit access for women to the monitoring of pre-cancerous lesions.